MIGUEL ÁNGEL
LÓPEZ RUZ
PROFESOR TITULAR DE UNIVERSIDAD
Hospital Costa Del Sol
Marbella, EspañaPublications in collaboration with researchers from Hospital Costa Del Sol (9)
2024
-
The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers
Journal of Clinical Investigation, Vol. 134, Núm. 8
2022
-
DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks)
Viruses, Vol. 14, Núm. 3
2017
-
Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 3, pp. 487-494
2014
2008
-
Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903
Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092
2006
-
Impacto de los factores demográficos y psicosociales en la no adherencia a los fármacos antirretrovirales
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 24, Núm. 6, pp. 373-378
2005
-
Clinical status, adherence to HAART and quality of life in HIV-infected patients receiving antiretroviral treatment
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 23, Núm. 10, pp. 581-585
-
Health-related quality of life of patients with HIV: Impact of sociodemographic, clinical and psychosocial factors
Quality of Life Research, Vol. 14, Núm. 5, pp. 1301-1310
-
Simplicity and efficacy of a once-daily antiretroviral regimen with didanosine, lamivudine, and efavirenz in naïve patients: The VESD study
HIV Clinical Trials, Vol. 6, Núm. 6, pp. 320-328